Literature DB >> 4970687

Phosphorylation and inactivation of kanamycin by Pseudomonas aeruginosa.

H Umezawa, O Doi, M Ogura, S Kondo, N Tanaka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4970687     DOI: 10.7164/antibiotics.21.154

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  8 in total

Review 1.  Aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

Review 2.  Julian Davies and the discovery of kanamycin resistance transposon Tn5.

Authors:  Douglas E Berg
Journal:  J Antibiot (Tokyo)       Date:  2016-10-12       Impact factor: 2.649

3.  Phosphorylation of kanamycin, lividomycin A, amd butirosin B by Providencia stuartii.

Authors:  P B Marengo; M E Chenoweth; G D Overturf; J Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

4.  Molecular characterization of the R factors implicated in the carbenicillin resistance of a sequence of Pseudomonas aeruginosa strains isolated from burns.

Authors:  L C Ingram; M H Richmond; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

5.  Activity of lividomycin against Pseudomonas aeruginosa: its inactivation by phosphorylation induced by resistant strains.

Authors:  F Kobayashi; M Yamaguchi; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1972-01       Impact factor: 5.191

6.  Antibacterial activity of lividomycin toward R factor-resistant strains of Escherichia coli.

Authors:  M Yamaguchi; F Kobayashi; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

7.  In vitro studies with UK-18,892, a new aminoglycoside antibiotic.

Authors:  S Jevons; H E Cheeseman; K W Brammer
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

8.  Phosphorylation of lividomycin by Escherichia coli carrying an R factor.

Authors:  M Yamaguchi; T Koshi; F Kobayashi; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.